Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 64, Issue s1, Pages S555-S565
Publisher
IOS Press
Online
2018-06-18
DOI
10.3233/jad-179937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Harnessing the Immune System for Treatment and Detection of Tau Pathology
- (2018) Erin E. Congdon et al. JOURNAL OF ALZHEIMERS DISEASE
- AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
- (2017) Christina Ising et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
- (2017) Michael G. Agadjanyan et al. Molecular Neurodegeneration
- Tau PET imaging: present and future directions
- (2017) Laure Saint-Aubert et al. Molecular Neurodegeneration
- Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
- (2017) William A. McEwan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
- (2017) Kiran Yanamandra et al. Science Translational Medicine
- Tau passive immunization inhibits not only tau but also Aβ pathology
- (2017) Chun-ling Dai et al. Alzheimers Research & Therapy
- Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
- (2017) Einar M. Sigurdsson JOURNAL OF ALZHEIMERS DISEASE
- Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
- (2017) Hameetha Rajamohamedsait et al. Scientific Reports
- Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach
- (2016) Dov B. Shamir et al. Alzheimers & Dementia
- Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
- (2016) Nicolas R. Barthélemy et al. JOURNAL OF ALZHEIMERS DISEASE
- Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
- (2016) Tengfei Li et al. JOURNAL OF CONTROLLED RELEASE
- Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice
- (2016) Wencheng Liu et al. JOURNAL OF NEUROSCIENCE
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
- (2016) Nicolas R Barthélemy et al. JOURNAL OF PROTEOME RESEARCH
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
- (2016) Erin E. Congdon et al. Molecular Neurodegeneration
- Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
- (2016) Seung-Hye Lee et al. Cell Reports
- Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
- (2016) Diana L. Castillo-Carranza et al. JOURNAL OF ALZHEIMERS DISEASE
- Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau
- (2015) Sayuri Taniguchi-Watanabe et al. ACTA NEUROPATHOLOGICA
- Distinct Therapeutic Mechanisms of Tau Antibodies
- (2015) Kristen E. Funk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies
- (2015) Sulana K. Schroeder et al. Journal of Neuroimmune Pharmacology
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
- (2015) Asami Kondo et al. NATURE
- Tau immunization: a cautionary tale?
- (2015) Alexandra J. Mably et al. NEUROBIOLOGY OF AGING
- Human secreted tau increases amyloid-beta production
- (2015) Jessica Bright et al. NEUROBIOLOGY OF AGING
- Tau Immunotherapy
- (2015) Einar M. Sigurdsson Neurodegenerative Diseases
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
- (2015) Wenjie Luo et al. Scientific Reports
- Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
- (2015) Sethu Sankaranarayanan et al. PLoS One
- Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
- (2015) Cristina d’Abramo et al. PLoS One
- MONITORING TAU PATHOLOGY AND MONOCLONAL ANTIBODIES IN VIVO BY TWO-PHOTON IMAGING
- (2014) Jiaping Gu et al. Alzheimers & Dementia
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
- (2014) Chun-ling Dai et al. JOURNAL OF NEURAL TRANSMISSION
- Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
- (2014) Arne Ittner et al. JOURNAL OF NEUROCHEMISTRY
- Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
- (2014) Maj-Linda B Selenica et al. Journal of Neuroinflammation
- Antibody-Derived In Vivo Imaging of Tau Pathology
- (2014) S. Krishnaswamy et al. JOURNAL OF NEUROSCIENCE
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
- (2014) Ken C. Walls et al. NEUROSCIENCE LETTERS
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- “Prion-Like” Templated Misfolding in Tauopathies
- (2013) Florence Clavaguera et al. BRAIN PATHOLOGY
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
- (2013) Cristina d’Abramo et al. PLoS One
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
- (2012) Najla Kfoury et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of Protein Seeding in Neurodegenerative Diseases
- (2012) Lary C. Walker et al. JAMA Neurology
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
- (2011) Mian Bi et al. PLoS One
- Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
- (2011) Pavan K. Krishnamurthy et al. Frontiers in Psychiatry
- Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy
- (2010) Allal Boutajangout et al. Alzheimers & Dementia
- Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
- (2010) Moran Boimel et al. EXPERIMENTAL NEUROLOGY
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now